GPT Healthcare IPO: As of 5 p.m., 8.52 times had been subscribed to the IPO; QIBs had subscribed 17.30 times their quota, while the NII component had subscribed more than 11 times.
In short
- On the last day, the GPT Healthcare IPO was oversubscribed.
- QIBs and NIIs exhibit robust demand for the IPO.
- Despite decreased demand, the retail investor quota was also oversubscribed.
GPT Healthcare’s initial public offering (IPO) was oversubscribed on the final day of bidding on Monday.
On the last day, the IPO gained momentum thanks to a significant push from qualified institutional investors (QIBs) and non-institutional investors (NIIs).
As of 5 p.m., the GPT Healthcare IPO had been subscribed 8.52 times, with QIBs subscribing 17.30 times their quota and the NII portion subscribed more than 11 times.
Even though retail investor demand was only 2.44 times the subscription, it was still better than it had been in the previous two days.
The unlisted shares of GPT Healthcare traded on the gray market at a premium of Rs 9 on the last day of subscription. A listing gain of less than five percent would result from the stock listing at the current GMP.
Key features of the GPT Healthcare IPO
Known by its other name, GPT Healthcare Ltd., or ILS Hospitals, is a major player in the area healthcare market with a primary emphasis on secondary and tertiary care services.
The organization provides an extensive range of healthcare solutions covering over 35 specialties and super specialties, and it operates a network of four multispecialty hospitals located in West Bengal and Tripura.
The IPO, valued at Rs 525.14 crore, is made up of a fresh issue of approximately 22 lakh shares worth Rs 40 crore and an offer-for-sale (OFS) of 2.61 million shares for Rs 485.14 crore.
The company’s shares are expected to make their debut on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) on February 29. The IPO’s share allotment is expected to take place on February 27.
The GPT Healthcare IPO is priced between Rs 177 and Rs 186 per share and requires a minimum investment of Rs 14,880 from retail investors.
Read Also: https://stockeasynow.com/gpt-healthcares-ipo-is-now-available-for-subscription/
Institutional investors must invest in a minimum of 14 lots (1,120 shares), totaling Rs 208,320, and non-institutional investors may consider investing in 68 lots (5,440 shares), equivalent to Rs 1,011,840.
Despite its vast service offerings and strong geographical presence, the IPO’s subscription rates suggest a cautious investor mindset.
Anand Rathi has given the IPO a “Subscribe – Long Term” rating, citing the company’s aim to strengthen its existing facilities and expand its service offerings.
Meanwhile, Mehta Equities’ IPO report highlights the company’s ability to enter adjacent areas with asset-light business models, such as Ranchi.
However, the brokerage recommended investors carefully assess their alternatives, citing the IPO’s structure, which consists entirely of an Offer For Sale (OFS), generating worries among novice investors.
According to Mehta Equities, only high-risk investors should contemplate subscribing to the IPO for the long term, whilst conservative investors may want to monitor the stock’s performance after it is listed.
